ScoreWhy is Maat Pharma SA ?
1
The company has declared Negative results for the last 3 consecutive quarters
- INTEREST(HY) At EUR 0.42 MM has Grown at 61.07%
- RAW MATERIAL COST(Y) Grown by 51.96% (YoY)
- CASH AND EQV(HY) Lowest at EUR 15.04 MM
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Maat Pharma SA for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Maat Pharma SA
2.85%
-0.23
73.96%
France CAC 40
0.34%
-0.10
17.53%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
45.89%
EBIT Growth (5y)
-214.97%
EBIT to Interest (avg)
-18.64
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.89
Sales to Capital Employed (avg)
0.07
Tax Ratio
10.85%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.67%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
15.48
EV to EBIT
-3.54
EV to EBITDA
-3.73
EV to Capital Employed
38.91
EV to Sales
31.43
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-1098.83%
ROE (Latest)
-375.32%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend3What is working for the Company
NET PROFIT(HY)
Higher at EUR -15.09 MM
INVENTORY TURNOVER RATIO(HY)
Highest at 24.1 times
-7What is not working for the Company
INTEREST(HY)
At EUR 0.42 MM has Grown at 61.07%
RAW MATERIAL COST(Y)
Grown by 51.96% (YoY
CASH AND EQV(HY)
Lowest at EUR 15.04 MM
DEBT-EQUITY RATIO
(HY)
Highest at -7.63 %
DEBTORS TURNOVER RATIO(HY)
Lowest at 0.29 times
Here's what is working for Maat Pharma SA
Net Profit
Higher at EUR -15.09 MM
than preceding 12 month period ended Jun 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (EUR MM)
Inventory Turnover Ratio
Highest at 24.1 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Here's what is not working for Maat Pharma SA
Interest
At EUR 0.42 MM has Grown at 61.07%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (EUR MM)
Cash and Eqv
Lowest at EUR 15.04 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debt-Equity Ratio
Highest at -7.63 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Debtors Turnover Ratio
Lowest at 0.29 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Raw Material Cost
Grown by 51.96% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
